Objective is new generation of therapeutics for allergy treatment
This year the most important European congress, the "European Academy of Allergy and Clinical Immunology" (EAACI), took place in Copenhagen...
The Global Asthma and Allergy European Network (GA²LEN) together with three allergen immunotherapy companies – Allergopharma, Laboratorios...
Marco Linari (43) became CEO of Allergopharma, the global Allergy business unit of the Merck Group. He succeeded Uta Kemmerich-Keil, who...